Rogaine
for Women ® ( Minoxidil )
Definition: Minoxidil is the main ingredient
of the brand name drug Rogaine, a topical lotion that was
the first drug to be approved by the FDA for the treatment
of androgentic alpecia (genetic hair loss). Now available
in varying degrees of strength from 2 to 5 percent, minoxidil
requires twice a day applications. The rate of effectiveness
varies between the 2 percent formula and 5 percent formula.
For women, the 2 percent version can improve hair regrowth
in 6 out of 10 women. Although a 5 percent version has been
clinically tested on women, and proven superior to the 2
percent, Pfizer has not issued a 5 percent minoxidil version
for women.
Clarification: Rogaine should not be confused
with Regain (a questionable hair loss product trying to
capitalize on the Rogaine's name), Progain (a shampoo marketed
by Rogaine maker Pfizer trying to capitalize on their own
brand name by making it sound similar to Rogaine). Minoxidil
is sometimes misspelled and spelled differently in other
countries as: Minoxidal, Minoxedal, Minoxidel, and even
Minoxidile. In the United Kingdom, Europe and Asia Pacific,
it is marketed under the brand name Regaine, eerily similar
but unrelated to Regain, mentioned above.
Minoxidil for Women
Rogaine for Women (minoxidil) is the only FDA approved
treatment for hereditary hair loss in women. According to
the International Society of Hair Restoration Surgeons,
Rogaine might actually be more effective for women, than
it is for men. (10) Clinical studies report that 6 in 10
women saw minimal to moderate hair regrowth with the 2 percent
version.
In clinical studies of mostly white women aged 18-45
years with mild to moderate degrees of hair loss, the
following response to 2% minoxidil topical solution was
reported: 19% of women reported moderate hair regrowth
after using 2% monoxidil topical solution for 8 months
(19% had moderate regrowth; 40% had minimal regrowth).
This compares with 7% of women reporting moderate hair
regrowth after using the placebo, the liquid without minoxidil
in it, for 8 months (7% had moderate regrowth; 33% had
minimal regrowth). (7,8)
In women with permanent, genetic hair loss, family history
can be an indicator of whether or not a woman will suffer
from some degree of genetic hair loss. Women with older
mothers, aunts and grandmothers with thinning hair are more
likely themselves to have female pattern hair loss.
"The cause of the failure to grow new hair in
female pattern baldness is not well understood, but it
is associated with genetic predisposition, aging (tied
to menopause/changes in hormone levels) and levels of
endocrine hormones (particulary androgens, the male sex
hormones). - MedlinePlus "Changes in the
levels of the androgens (a male hormone) can affect hair
production. For example, after the hormonal changes of
menopause, many women find that the hair on the head is
thinned, while facial hair is coarser." (11)
The good news for women is that Rogaine for Women®
"... helps to reverse the progression of hereditary
hair loss." (8)
For men, the only FDA approved treatment options for hair
loss are Rogaine, and Finasteride (Propecia) a hormone based
treatment. Women are prohibited from using finasteride since
birth defects can be a major side effect.
Since hormonal based treatments are not an option for women,
Rogaine for Women has proven to be a successful product
in a market with 30 million women who suffer from genetic
hair loss and thinning hair. The bonus for women is that
for some reason, no one seems to know why, topical minoxidil
has proven more effective in treating hair loss in women
then it has in men. (10)
Currently, Rogaine for Women comes in the 2 percent formulation.
Although a study comparing a 5 percent version to a 2 percent
version was concluded in 2004 on 381 women, Pfizer still
has not released a 5 percent version for women.
"At week 48, the 5% topical minoxidil group
demonstrated statistical superiority over the 2% topical
minoxidil group in the patient assessment of treatment
benefit. Both concentrations of topical minoxidil were
well tolerated by the women in this trial without evidence
of systemic adverse effects," the report stated.
It's worth noting that the report also cautioned against
the rise in "herbal treatments" masquerading as
treatments for women's hair loss.
"With the introduction of numerous herbal remedies
for hair loss, of which most have not been tested in randomized,
double-blind, placebo-controlled trials, it is important
to describe well-controlled trials that demonstrate the
efficacy and safety of topical drugs."

|